SynthesisOncotarget2017

Comparative effectiveness of combined therapy inhibiting EGFR and VEGF pathways in patients with advanced non-small-cell lung cancer: a meta-analysis of 16 phase II/III randomized trials.

Yongzhao Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.